1. Home
  2. CORT vs APPF Comparison

CORT vs APPF Comparison

Compare CORT & APPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$117.17

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Logo AppFolio Inc.

APPF

AppFolio Inc.

HOLD

Current Price

$195.97

Market Cap

6.4B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CORT
APPF
Founded
1998
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
6.4B
IPO Year
2001
2015

Fundamental Metrics

Financial Performance
Metric
CORT
APPF
Price
$117.17
$195.97
Analyst Decision
Buy
Strong Buy
Analyst Count
5
9
Target Price
$96.50
$286.78
AVG Volume (30 Days)
1.2M
440.0K
Earning Date
04-30-2026
04-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
2.36
Revenue
$761,407,000.00
$950,822,000.00
Revenue This Year
$26.08
$19.69
Revenue Next Year
$26.98
$16.70
P/E Ratio
$1,271.89
$86.53
Revenue Growth
12.79
19.72
52 Week Low
$28.66
$142.56
52 Week High
$122.21
$285.61

Technical Indicators

Market Signals
Indicator
CORT
APPF
Relative Strength Index (RSI) 66.55 56.89
Support Level $76.41 $157.79
Resistance Level $122.21 $240.32
Average True Range (ATR) 5.00 8.53
MACD -0.00 0.61
Stochastic Oscillator 81.48 67.02

Price Performance

Historical Comparison
CORT
APPF

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

About APPF AppFolio Inc.

AppFolio Inc provides cloud-based software solutions for the real estate industry. Its property management software offers property managers an end-to-end solution to their business needs. The group's products include cloud-based property management software (Appfolio Property Manager). Its solutions are AppFolio Property Manager Core, AppFolio Property Manager Plus, and AppFolio Property Manager Max. It also offers value-added services, such as screening, risk mitigation, and electronic payment services. Its markets are Single-Family, Multifamily, Student Housing, Affordable Housing, Community Associations, Commercial, and Investment Management. The business activity of the firm predominantly functions in the United States and it generates revenue in the form of subscription fees.

Share on Social Networks: